First Real-World Data on Unresectable Stage III NSCLC Patients Treated with Durvalumab after Chemoradiotherapy in Asia Area

Kuo, C.C.KuoYang, T.-Y.T.-Y.YangWang, C.-C.C.-C.WangHua, C.C.C.C.HuaHsia, T.-C.T.-C.HsiaChiang, C.-L.C.-L.ChiangJEN-CHUNG KOTsai, C.-L.C.-L.TsaiSu, P.-L.P.-L.SuSu, J.J.SuHo, C.-C.C.-C.HoChang, G.-C.G.-C.Chang2026-04-202026-04-202022-09https://scholars.lib.ntu.edu.tw/handle/123456789/737325First Real-World Data on Unresectable Stage III NSCLC Patients Treated with Durvalumab after Chemoradiotherapy in Asia Areajournal article10.1016/j.jtho.2022.07.449